GENB
Generate Biomedicines, Inc.
A Massachusetts biotech company that uses machine learning to design entirely new protein-based medicines from scratch, rather than hunting for molecules that already exist in nature. Founded in 2018 inside Flagship Pioneering's incubator, it spent its first three years in stealth before publicly launching its platform in 2020. The name reflects the mission: where other firms "discover" drugs, this one *generates* them.
CUSIP: 370920100HealthcareUS2 holders
Total Value
$28.03M
Total Shares
1.79M
Net Share Change
+1.29M
Activity
2 buying
Investor
Value
Shares
Weight
Change
